These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4006315)

  • 21. Naloxone-reversible inhibition by opiates of phagocytosis in Tetrahymena thermophila and mouse macrophages.
    Casellas AM; De Jesus S; Guardiola H; Renaud FL
    P R Health Sci J; 1988 Aug; 7(2):103-5. PubMed ID: 2847209
    [No Abstract]   [Full Text] [Related]  

  • 22. Infusion of opiates into substantia nigra protects against maximal electroshock seizures in rats.
    Garant DS; Gale K
    J Pharmacol Exp Ther; 1985 Jul; 234(1):45-8. PubMed ID: 2989511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of mu-opioid receptor agonists on circulatory responses to simulated haemorrhage in conscious rabbits.
    Evans RG; Ludbrook J
    Br J Pharmacol; 1990 Jul; 100(3):421-6. PubMed ID: 2167731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contractile effect of morphine and related opioid alkaloids, beta-endorphin and methionine enkephalin on the isolated colon from Long Evans rats.
    Huidobro-Toro JP; Way EL
    Br J Pharmacol; 1981 Nov; 74(3):681-94. PubMed ID: 6170377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The adenylate cyclase rebound response to naloxone in the NG108-15 cells. Effects of etorphine and other opiates.
    Musacchio JM; Greenspan DL
    Neuropharmacology; 1986 Aug; 25(8):833-7. PubMed ID: 3022177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of morphine and (D-Ala, Met)-enkephalinamide on 45Ca-uptake to rat brain striatal slices.
    Saito K; Fujita N; Nakahiro M; Inoki R
    Neuropeptides; 1984 Dec; 5(1-3):57-60. PubMed ID: 6531075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naloxone-insensitive modulation of gastric acid output by [D-Met2,Pro5]enkephalinamide in rats.
    Till M; Szombath D; Gáti T; Székely JI
    Eur J Pharmacol; 1990 Jan; 175(3):355-8. PubMed ID: 2323351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioids and breathing.
    Santiago TV; Edelman NH
    J Appl Physiol (1985); 1985 Dec; 59(6):1675-85. PubMed ID: 2934364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seasonal difference in thermoregulatory responses to opiates in a mammalian hibernator.
    Wang LC; Lee TF; Jourdan ML
    Pharmacol Biochem Behav; 1987 Mar; 26(3):565-71. PubMed ID: 3575372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noradrenergic terminal excitability: effects of opioids.
    Nakamura S; Tepper JM; Young SJ; Ling N; Groves PM
    Neurosci Lett; 1982 May; 30(1):57-62. PubMed ID: 6124916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of [D-Met2,Pro5]enkephalinamide on gastric ulceration and transmucosal potential difference.
    Till M; Gáti T; Rábai K; Szombath D; Székely JI
    Eur J Pharmacol; 1988 Jun; 150(3):325-30. PubMed ID: 3416913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opiates modulation of cAMP levels and PGE2 binding in mammalian sympathetic ganglia.
    Borasio PG; Biondi C; Capuzzo A; Ferretti ME
    Neurosci Lett; 1986 May; 66(1):7-12. PubMed ID: 2872633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance to morphine bradycardia in the rat.
    Kiang JG; Dewey WL; Wei ET
    J Pharmacol Exp Ther; 1983 Jul; 226(1):187-91. PubMed ID: 6864538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain.
    Ventayol P; Busquets X; Garcia-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):491-500. PubMed ID: 9109366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opiate modulation of the pituitary-adrenal axis: effects of stress and circadian rhythm.
    Grossman A; Gaillard RC; McCartney P; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1982 Sep; 17(3):279-86. PubMed ID: 6299620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of a synthetic enkephalin analogue during heroin withdrawal.
    Holmstrand J; Gunne LM
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Mar; 13(2):68-71. PubMed ID: 7437134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceruletide inhibits water intake in deprived mice: comparison with morphine and the enkephalin analogue, FK 33-824.
    Zetler G; Raberg A
    Eur J Pharmacol; 1985 Aug; 114(3):247-51. PubMed ID: 2998807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential modification of opiate receptor activity by arylsulfatase treatment.
    Garzón J; Jen MF; Lee NM
    Biochem Pharmacol; 1983 May; 32(9):1523-8. PubMed ID: 6134534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opiate alkaloids antagonize postsynaptic glycine and GABA responses: correlation with convulsant action.
    Werz MA; Macdonald RL
    Brain Res; 1982 Mar; 236(1):107-19. PubMed ID: 7066678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.